Deepika Malik

Deepika Malik practices at Ophthalmic Consultants of Long Island in Oceanside, New York.

Deepika Malik's NPI, 1134530306, was assigned on May 9, 2014. Deepika Malik holds New York license 316968.

Deepika Malik's primary practice is Ophthalmic Consultants of Long Island, at 2860 Long Beach Rd, Oceanside, NY 11572 in Nassau County. The practice phone is (516) 766-2519.

Deepika Malik's primary practice is Ophthalmic Consultants of Long Island in Oceanside, New York. The medical group on file is Drexel Psychological Services Center. Dmand AI also links Deepika Malik to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Deepika Malik practices. Vendor and product names are available with a free account.

Retina specialist is Deepika Malik's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Deepika Malik is licensed in New York.

CMS data shows 27,999 Medicare services from Deepika Malik across 28 procedure codes in 2024, for 1,320 Medicare patients. Medicare paid $2,422,046 for them.

CMS counts 1,320 Medicare patients who saw Deepika Malik in 2024. The largest group is 75 to 84, with 494 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Deepika Malik's median patient age at 71, with 53% women.

In 2024, Deepika Malik wrote 1,052 Medicare Part D claims for 329 patients. 59% of them were for generic drugs. CMS names the drug for 941 of them, across 15 drugs with 11 or more claims each, at $39,277 in total drug cost. In 2023, CMS named 277 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Deepika Malik for performance year 2024, reported as part of a group. Deepika Malik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 23 procedures of cataract surgery by Deepika Malik, more than 47% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Deepika Malik, published from 2013 to 2023. 2013 was the busiest year, with 2. The most frequent topics are DNA, Mitochondrial, Polymorphism, Single Nucleotide and Mitochondria. Deepika Malik has published most often in Case Rep Ophthalmol Med. Deepika Malik's most frequent co-authors are David S. Boyer, MD, Payam Falatoonzadeh, MD and Baruch D. Kuppermann, MD.

CMS Open Payments shows 436 general payments to Deepika Malik from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $71,475. It also lists 5 research payments totaling $7,648 from 2017 to 2025.